PSHNX Performance — Penn Capital Short Duration High Income Fund, Institutional Class
Data updated: 2026-07-28
PSHNX returned +1.63% year to date and +6.56% over one year to May 2026. Annualised returns are +7.48% over 3 years and +4.83% over 5 years. The fund beat its Short-Term Corporate Bond category average: $100 invested three years ago grew to $124, against $122 for the category, and to $107 over one year, against $106. Volatility over the past three years was 2.25% a year. In the 12 months to May 2026 the fund took in a net $2.7M, and assets reached $20.26M.
PSHNX Growth of $100
What $100 invested in Penn Capital Short Duration High Income Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Short-Term Corporate Bond category average over the same months.
| Period | PSHNX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $107 | $106 |
| 3 years (Jun 2023 – May 2026) | $124 | $122 |
| 5 years (Jun 2021 – May 2026) | $127 | $117 |
| Since data start (Jan 2020 – May 2026) | $130 | $125 |
PSHNX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +1.63% |
| 1 year | +6.56% |
| 3 years (annualised) | +7.48% |
| 5 years (annualised) | +4.83% |
PSHNX Annual Returns
Calendar-year total returns of Penn Capital Short Duration High Income Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +1.63% |
| 2025 | +7.72% |
| 2024 | +7.19% |
| 2023 | +8.72% |
| 2022 | −2.28% |
| 2021 | +3.42% |
| 2020 | +0.89% |
PSHNX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.3% | +0.4% | −0.6% | +1.1% | +0.4% | — | — | — | — | — | — | — |
| 2025 | +1.2% | +0.4% | −0.4% | −0.2% | +1.7% | +1.3% | +0.4% | +0.8% | +0.6% | +0.2% | +0.7% | +0.7% |
| 2024 | +0.5% | +0.2% | +0.9% | −0.1% | +0.8% | +0.8% | +1.2% | +0.9% | +0.9% | 0.0% | +1.0% | −0.2% |
| 2023 | +1.8% | −0.1% | +0.7% | +0.7% | −0.3% | +1.0% | +0.8% | +0.3% | −0.3% | −0.2% | +2.5% | +1.6% |
| 2022 | −1.3% | −0.4% | −0.2% | −1.1% | +0.1% | −3.1% | +3.1% | −0.6% | −1.1% | +1.6% | +0.8% | +0.2% |
| 2021 | +0.2% | +0.3% | +0.6% | +0.5% | +0.4% | +0.5% | +0.1% | +0.3% | 0.0% | +0.2% | −0.6% | +1.0% |
| 2020 | +0.1% | −1.1% | −7.8% | +2.1% | +1.8% | +0.5% | +2.3% | +0.8% | −0.3% | +0.1% | +1.9% | +1.0% |
PSHNX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 2.25%
- 3-year Sharpe ratio: 1.32 (vs 4.5% risk-free rate)
- Best month: +2.45% (Nov 2023)
- Worst month: −0.57% (Mar 2026)
PSHNX Fund Flows
Monthly money in and out of Penn Capital Short Duration High Income Fund, from SEC Form N-PORT.
- 12-month net flow: $2.7M
- 12-month gross sales (incl. reinvestments): $6.8M
- Sales ÷ redemptions: 1.67×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $347K | $468K | −$121K |
| Apr 2026 | $99K | $1.3M | −$1.2M |
| Mar 2026 | $3.3M | $112K | $3.2M |
| Feb 2026 | $125K | $103K | $21K |
| Jan 2026 | $397K | $210K | $187K |
| Dec 2025 | $1K | $152K | −$151K |
| Nov 2025 | $1.7M | $315K | $1.3M |
| Oct 2025 | $232K | $511K | −$279K |
| Sep 2025 | $153K | $614K | −$461K |
| Aug 2025 | $212K | $153K | $59K |
| Jul 2025 | $2K | $65K | −$63K |
| Jun 2025 | $279K | $85K | $194K |
PSHNX Assets Under Management
Net assets of Penn Capital Short Duration High Income Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $20.26M |
| 2026-02-28 | $18.47M |
| 2025-11-30 | $18.45M |
| 2025-08-31 | $17.83M |
| 2025-05-31 | $17.46M |
| 2025-02-28 | $15.42M |
| 2024-11-30 | $15.52M |
| 2024-08-31 | $16.56M |
| 2024-05-31 | $17.09M |
| 2024-02-29 | $18.86M |
| 2023-11-30 | $30.97M |
| 2023-08-31 | $31.30M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.